You had it before. You're terrified it's happening again. Here is what you actually control.
Russell W. Raskin, MD · Board-Certified Emergency Medicine & Internal Medicine · R.W. Raskin Health Protocols, LLC
You had it before. Maybe it was last year. Maybe longer ago than that. It laid you out for two weeks, three weeks, maybe a month. You couldn't work. You couldn't think straight. Every cough triggered another cough. By the time it ended, you were exhausted in a way sleep didn't fix.
Currently you've got a cold. A scratchy throat, runny nose, maybe a slight cough. But you're watching it carefully. Because you're terrified it's going to turn into that again.
That fear has been given a name by Russell W. Raskin, MD.
R.W. Raskinism
Post-Traumatic Bronchitis Disorder — PTBD.
You're not sick with bronchitis right now. You're sick with the fear and the memory of bronchitis. And that fear and memory are coloring every decision you make in this moment.
You're thinking about calling your doctor for an antibiotic.
An antibiotic does not prevent nor treat bronchitis. It did not prevent it or treat it the last time. It will not prevent it or treat it this time. What it can do is add risk.
And what you actually control — what determines whether this becomes a one-week illness or a three-week disaster — is something far simpler and far harder.
It's rest.
And that rest means doing nothing. It means stopping work. It means stopping talking. It means sitting on your couch or lying in your bed and letting your body do what it's designed to do. It means not convincing yourself on day three that you're fine when you're not fine yet.
This is the hardest prescription I have to write. Patients don't want to hear it. They want a pill. They want to keep working. They want to keep moving. But the pill doesn't work. And the moment you decide you're well enough to push through — that's the moment you extend the arc. That's the moment a one-week cold becomes three weeks.
You cannot substitute rest with a medication you don't need. You cannot skip the actual work and expect a pill to do it for you.
So Here's the Plan.
This is what got me through this week. Wednesday I felt off. Thursday I was coughing at work. Friday morning I woke up laid out with a deep cough that took me straight back to my PTBD moment — oh my god, here we go again. But Friday I stopped everything. I rested. I followed the Four Pillars. And by Sunday I was on the other side. By Monday I was back at work.
Read the full article
Raskin's Four Pillars of Immune Optimization →
But for bronchitis, one pillar matters more than the others.
R.W. Raskinism
Absolute rest. Not rest when you feel like it. Not general rest. Absolute rest. The moment you know you're sick, you stop.
You stop work. You stop talking unnecessarily. You stop moving. You sleep. You let your immune system engage at full capacity without the interference of your daily life. This is where most patients fail. They wait until they're forced to stop. By then, the arc is already steep. Stop on day one. That changes everything.
What You Control, What You Don't
Whether your cold becomes bronchitis depends on the specific virus you catch and how your immune system responds. You don't control that. But whether that bronchitis becomes a one-week illness or a three-week nightmare? That you have some control over. And it's determined by one thing: whether you rest on day one, or whether you wait until you're forced to.
The patients who rest early shorten the arc. The patients who push through extend it. The patients who rest absolutely — who stop work, stop talking, stop moving — those are the ones who get through it fastest. That's not a guess. That's what I've proven over and over again with my patients. That's what I've just proven with myself.
How You Know You're Turning the Corner
You'll know the arc begins its descent when that miserable feeling in your chest changes. That tickle — the one that tells you every time you talk or exert yourself you're about to become paralyzed with a cough. And that discolored mucus — the thick, stubborn kind that announces the plateau has arrived. When that begins to clear, when it starts to dry up, when the tickle in your chest begins to quiet — that's your signal. That's your body telling you you're on the road to recovery.
Don't mistake the plateau for failure. It's not. It's your immune system doing exactly what it was programmed to do. Trust it.
The Prescription
If it isn't already clear — antibiotics and other medications do not help garden variety bronchitis. The only thing that works is a plan. In this case, a protocol. Follow it and the best outcome will likely be yours.
You need permission to stop. You need to understand that rest isn't weakness. It is the intervention. It is the medicine.
If you think it is something more than bronchitis, go see your doctor — armed with the knowledge you've gained here. If it is bronchitis, and your doctor is following the science, what you need is a work note, time, and the protocol. Take all three and trust the arc.
Related reading
Is It a Cold, Bronchitis, or Pneumonia? →
SYC Defense Protocol
The arc starts before you get sick. SYC Defense Protocol is the daily immune maintenance stack built to keep your baseline where it needs to be — so that when you do encounter a virus, your immune system is ready to respond.
You don't need an antibiotic for a cold. You need a plan.
Join the Movement
Your doctor should be getting this right. Now you'll know when they may not be.
Want to go deeper?
The clinician version isn't just for doctors. It's the same topic, written for physicians — the full reasoning, nothing simplified. You're allowed to read it. Read the clinician version →
HCP Guide — Peer to Peer · Russell W. Raskin, MD
Bronchitis: Cut the Crap
Fifty years of evidence. Your prescription pad hasn't read a word of it.
Russell W. Raskin, MD · Board-Certified Emergency Medicine & Internal Medicine · R.W. Raskin Health Protocols, LLC
You should have been taught this in medical school. You should be following the evidence. Yet nobody is watching you to see that you are doing this. I'm guessing you may be doing this wrong. Your prescription pad tells me it's so.
The evidence against antibiotics for acute bronchitis has been accumulating since 1976. Not 2001. Not 2017. 1976. Stott and West randomized patients with purulent cough to doxycycline versus placebo. No difference in cough duration. No difference in sputum. No difference in days missed from work. No difference in how sick patients felt.
That was fifty years ago.
The Evidence Timeline
Year
Study / Guideline
Finding
Verdict
1976
Stott & West RCT
Doxycycline vs. placebo — no difference across all outcomes
No benefit
1999
Meta-analysis, 8 RCTs
Antibiotics reduced cough by ~half a day — a "small benefit" the authors judged "not justified"
No benefit
2001
CDC / ACP / AAFP / IDSA
Routine antibiotics for uncomplicated acute bronchitis not recommended — regardless of cough duration
Against
2013
Little et al., Lancet Infect Dis, 2,061 patients, 12 countries
Amoxicillin: little symptomatic benefit over placebo [5]
No benefit
2017
Cochrane, 17 RCTs, 5,099 patients
Limited clinical benefit, increased adverse events, half a day difference at best
No benefit
2020
CHEST Expert Panel
Against routine prescription of any pharmacologic therapy for acute bronchitis
Any. At all.
The Therapeutic Cabinet Is Empty
Antibiotics
Evidence
Seventeen RCTs. 5,099 patients. Cochrane 2017. At best, half a day reduction in cough duration over an 8–10 day illness. Increased adverse events. ACP and CDC recommend against routine use. CHEST 2020 recommends against routine prescription of any pharmacologic therapy. [2,6,7]
Bronchodilators
Evidence
No benefit in patients without underlying asthma or COPD. The 2023 Llor et al. multiarm RCT (194 patients) randomized adults with uncomplicated acute bronchitis to dextromethorphan, ipratropium bromide, honey, or usual care. Median days with moderate-to-severe cough: 5–6 days in every single arm. Including usual care. Ipratropium did nothing. [11]
Corticosteroids
Evidence
The OSAC trial showed corticosteroids were not effective in adults without asthma presenting with acute lower respiratory tract infection. Not for cough duration. Not for symptom severity. Not routinely, for any outcome. [7]
Antitussives — Dextromethorphan, Codeine
Evidence
Codeine: no more effective than placebo in two trials. Dextromethorphan: no benefit in the most recent well-designed RCT (Llor 2023). Every arm performed identically. [11]
Benzonatate
Evidence + FDA Warning
FDA-approved since 1958. One placebo-controlled trial — negative. A 2025 prospective cohort of 718 patients: most commonly prescribed non-antibiotic for LRTI. Propensity score-matched analysis: no association with reduced cough duration, severity, or follow-up visits. [8]
FDA safety warning: Fatalities in children under 10 from accidental ingestion of as few as one or two capsules.
Narcotic Antitussives
Evidence + Safety
No RCT data specific to acute bronchitis. No evidence of benefit. The hydrocodone label warns against use in patients with productive cough — opioid suppression of the cough reflex may interfere with airway clearance. CHEST 2020 recommends against routine use of any antitussive class. [7]
NSAIDs / Mucolytics / Expectorants / Honey
Evidence
NSAIDs: ibuprofen vs. placebo — median 9 vs. 11 days. Not statistically significant. Mucolytics/expectorants/antihistamines: European Respiratory Society: do not prescribe in acute LRTI. Grade A1. [9] Honey: no benefit in adults. [11]
CHEST Expert Panel Report, 2020
"Insufficient evidence to confirm or refute the efficacy of prescribed treatments for cough due to acute bronchitis." — Smith MP et al. Chest. 2020;157(5):1256–1265.
That is the American College of Chest Physicians telling you the cabinet is empty. Every drawer. Every shelf. And yet — close to 100% of patients leave with a prescription of some sort. Every time. You know this because you are doing it. I know this because I did it too.
The One Exception That Proves the Rule
Clinically Defensible Carve-Out
The patient with known asthma or COPD is a different encounter. Bronchospastic disease changes the pathophysiology. Bronchodilators have a legitimate role during a virally-triggered exacerbation. Steroids may be appropriate. A lower threshold for antibiotics is warranted when bacterial superinfection is genuinely suspected in a compromised airway.
Know your patient. Treat the exacerbation, not the bronchitis.
This exception does not apply to the otherwise healthy adult with reactive bronchitis from RSV, rhinovirus, influenza, or any other viral URI without underlying pulmonary disease.
What You Cannot Do Is Not the Same As Nothing To Do
Here is where most of us fail our patients. We say "there's nothing I can give you" and we leave them adrift. The patient hears: you can't help me. They leave dissatisfied. They call back in three days. They find someone who will prescribe.
Saying there is nothing to give is not the same as saying there is nothing to do. And conflating the two is where the prescription pad fills a void it was never supposed to fill.
There is a plan. There is a protocol. And your job — your clinical value in that encounter — is to deliver it with the same authority you would give any other evidence-based intervention. Patient education and structured expectation-setting reduce antibiotic use, increase satisfaction, and improve outcomes. The plan works. You just have to give it. (Barrett B et al. Ann Fam Med. 2011;9(4):312–322.) [10]
Your patient needs three things from you in that encounter.
First — a diagnosis they can understand. Not "viral bronchitis." Not "it's going around." Tell them what is happening inside their airway. Their immune system is responding to a viral trigger. The bronchi are inflamed. The cough is the airway clearing itself. The discolored mucus is not a bacterial infection — it is the byproduct of immune engagement. Say that explicitly. It stops the "but it's discolored" argument before it starts.
Second — reframe the etiology argument before they make it. There is no practical test to distinguish viral from bacterial bronchitis in routine clinical practice — and it does not matter. Across 17 RCTs, antibiotics reduce cough duration by at most half a day regardless of cause. The etiology is irrelevant. The outcome data is not.
Third — name what they are feeling. Name it: Post-Traumatic Bronchitis Disorder — PTBD. Not a formal diagnosis. A clinical shorthand that tells your patient: I see what is happening here. You are not afraid of a cold. You are afraid of the memory of what bronchitis did to you. I understand. And I have something better than an antibiotic for you.
The Protocol — What You Actually Prescribe
Set the Arc
Tell them the cough may last two to three weeks. Sometimes longer. Tell them the plateau is not escalation — it is their immune system at maximum engagement. Tell them what the recovery signal looks like: when the discolored mucus begins to clear, when the tickle in the chest begins to quiet, when exertion no longer paralyzes them with coughing. The patient who understands the arc does not call back on day five panicking.
Prescribe Absolute Rest
Not general rest. Absolute rest. Stop work. Stop talking unnecessarily. Stop moving. Day one. This is the intervention that actually changes severity and duration. Write the work note. Without apology. Rest is the prescription. The work note is how you make it actionable.
Give Them the Four Pillars
Rest. Hydration and humidity. Stress management. Supplementation — zinc, quercetin, NAC, and vitamin C as part of a structured protocol may support immune function. Send them to the platform. Give them something to follow.
Platform resource
Raskin's Four Pillars of Immune Optimization →
Tell Them When to Come Back
Return Precautions — Give Explicitly
Higher fever or fever that returns after resolution
True difficulty breathing — not just discomfort or chest tightness
Symptoms lasting beyond three weeks
Chest pain
Hemoptysis
New confusion or altered mental status
Anything that doesn't seem right — when in doubt, get checked out
The Close
You went into medicine to help patients get better. A prescription for viral bronchitis does not do that. It exposes them to harm, contributes to resistance, and medicates a self-limiting condition that will resolve on its own — faster if they rest, slower if they don't.
R.W. Raskinism
Stop using the prescription pad as a shield. Start prescribing a plan — the protocol.
The plan is the medicine. The prescription pad was never the right tool. And now the protocol has a home. Rest. Hydration. Stress management. Supplementation. The arc explained. The expectations set. The patient educated and sent home with a framework, a work note, and a protocol designed to support their immune system through what it was already programmed to do.
That protocol now includes ZnPaC — a supplementation component designed to support the process. Zinc, quercetin, NAC, and vitamin C. Not a treatment. Not a shortcut. A piece of the optimization plan that works best when the whole plan is followed. Send your patients there. Give them the full protocol. That is the prescription.
Related reading
URI, Bronchitis, and Pneumonia — The Clinical Spectrum →
SYC Defense Protocol
The goal of SYC is to keep your patients off the arc in the first place. Daily immune maintenance, physician-designed, built for the days between illnesses.
The patient version is the plain-language take on the same topic — no jargon, no prescription pad. Built to hand a patient after the visit, so the conversation keeps going after they leave.
Gonzales R et al. Principles of Appropriate Antibiotic Use for Treatment of Uncomplicated Acute Bronchitis. Ann Emerg Med. 2001;37(6):720–727.
Smith SM et al. Antibiotics for Acute Bronchitis. Cochrane Database Syst Rev. 2017;6:CD000245.
Bent S et al. Antibiotics in Acute Bronchitis: A Meta-Analysis. Am J Med. 1999;107(1):62–67.
Smith SM et al. OTC Medications for Acute Cough. Cochrane Database Syst Rev. 2014;(11):CD001831.
Little P et al. Amoxicillin for Acute Lower-Respiratory-Tract Infection. Lancet Infect Dis. 2013;13(2):123–129.
Harris AM et al. Appropriate Antibiotic Use for Acute Respiratory Tract Infection. Ann Intern Med. 2016;164(6):425–434.
Smith MP et al. Acute Cough Due to Acute Bronchitis: CHEST Expert Panel Report. Chest. 2020;157(5):1256–1265.
Ebell MH et al. Corticosteroids, Antitussives, and Inhalers for Lower Respiratory Tract Infections. J Gen Intern Med. 2025. doi:10.1007/s11606-025-09733-x.
Woodhead M et al. Guidelines for the Management of Adult Lower Respiratory Tract Infections. Eur Respir J. 2005;26(6):1138–1180.
Barrett B et al. Treating the Common Cold. Ann Fam Med. 2011;9(4):312–322.
Llor C, Moragas A, Ouchi D, et al. Effectiveness of Antitussives, Anticholinergics, and Honey Versus Usual Care in Adults With Uncomplicated Acute Bronchitis: A Multiarm Randomized Clinical Trial. Fam Pract. 2023;40(2):407–413.
You don't need to tell your patients there is nothing to do. There is something to do. It is evidence-based, it is effective, and it is yours to give.
